IRVINE, CA / ACCESSWIRE / August 29, 2017 / Khang & Khang LLP (the “Firm”) announces a securities class action lawsuit against TechnipFMC plc (“TechnipFMC” or the “Company”) (NYSE: FTI). Investors who purchased or otherwise acquired shares between April 27, 2017 and July 24, 2017, inclusive (the “Class Period”), are encouraged to contact the Firm in advance of the October 2, 2017 lead plaintiff motion deadline.

If you purchased TechnipFMC shares during the Class Period, please contact Joon M. Khang, Esq., of Khang & Khang LLP, 4000 Barranca Parkway, Suite 250, Irvine, CA 92604, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

There has been no class certification in this case yet. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member as well.

According to the Complaint, throughout the Class Period, TechnipFMC made false and/or misleading statements, and/or failed to disclose: that the Company had a material weakness in its internal control over rates used in the calculations of the foreign currency effects on certain of its engineering and construction projects; that TechnipFMC lacked effective internal controls over financial reporting; and thus the Company’s public statements were materially false and misleading at all relevant times. On this news, shares of TechnipFMC dropped in value materially, which caused investors harm.

If you want to learn more about this lawsuit, or if you have any questions about this notice or your rights, please contact Joon M. Khang, Esq., a prominent litigator for almost two decades, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contact

Joon M. Khang, Esq.
Telephone: 949-419-3834
Facsimile: 949-225-4474
joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 474055

IRVINE, CA / ACCESSWIRE / August 29, 2017 / Khang & Khang LLP (the “Firm”) announces a securities class action lawsuit against TransDigm Group Incorporated (“TransDigm” or the “Company”) (NYSE: TDG). Investors who purchased or otherwise acquired shares between May 10, 2016 and January 19, 2017, inclusive (the “Class Period”), are encouraged to contact the Firm in advance of the October 10, 2017 lead
plaintiff motion deadline.

If you purchased TransDigm shares during the Class Period, please contact Joon M. Khang, Esq., of Khang & Khang LLP, 4000 Barranca Parkway, Suite 250, Irvine, CA 92604, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

There has been no class certification in this case yet. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member as well.

According to the Complaint, during the Class Period, TransDigm made false and/or misleading statements and/or failed to disclose: that the Company’s growth and profitability were artificially inflated as a result of its illicit business practices; that TransDigm used exclusive distributors to make noncompetitive government bids seems competitive; that the Company’s subsidiaries failed to list TransDigm as a parent entity when submitting government bids; and that as a result of the above, the Company’s statements about its business, operations, and prospects were false and misleading and/or lacked a reasonable basis. Upon release of this information, shares of TransDigm dropped in value materially, which caused investors harm according to the Complaint.

If you wish to learn more about this lawsuit, or if you have any questions regarding this notice or your rights, please contact Joon M. Khang, Esq., a prominent litigator for almost two decades, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contact

Joon M. Khang, Esq.

Telephone: 949-419-3834

Facsimile: 949-225-4474

joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 474057

NEW YORK, NY / ACCESSWIRE / August 29, 2017 / Teralytic has raised $2.25 million to bring its soil sensors and machine learning analytics to farmers. Teralytic’s solution helps farmers produce more food with fewer resources by improving their field’s soil health. 01 Ventures led the investment in Teralytic.

Soil testing is a manual, time-intensive process that takes days or weeks to collect, diagnose and respond to conditions in the field. With Teralytic’s sensors distributed around a farm constantly checking and reporting on the conditions of its soil quality 24 hours a day, 365 days a year, farmers no longer need to spend as much time manually testing soils and waiting for test results. Farmers are increasing their adoption of technology to help around the farm given the labor shortages impacting the agriculture industry and Teralytic has been helping farmers automate their soil sampling.

Teralytic’s sensors constantly gather data about soil quality, such as its temperature, moisture, pH and fertility levels, as well as in-field micro-climate data. Each sensor accurately measures more than 20 different data points, giving farmers real-time visibility into the condition of their soils. “By collecting and analyzing data in real-time, farms are less likely to over- or under-fertilize or mishandle watering programs throughout the growing season,” said Meagan Hynes, Ph.D., Teralytic’s VP of Soil Science. “I’m excited about the potential to use data to help improve soil health.”

Combined with machine learning and predictive analytics, the software platform helps farmers understand where problems may appear in their soils, enabling them to take proactive steps to prevent them from happening. Farmers, governments and land banks all use the soil quality data to quantify soil fertility and improve the value of their crops and land as well as cut input costs. By preventing over fertilization, farmers can also reduce costs and environmental impacts.

Low-cost innovations in the Internet of Things space are also helping bring new ways of collecting data to the farm. “Materials science innovations and the continual advancement of microfabrication techniques have blown the doors open to produce cutting-edge sensor tech at scale,” said Ryan Mansergh, Ph.D., Teralytic’s VP of R&D. “These sensors–coupled with AI, machine learning, and cloud technologies–have finally made it possible to deliver on the promise of precision agriculture–and the timing couldn’t be better, as we need to increase crop yields with fewer inputs if we hope to continue feeding the world’s growing population.”

Combining sensor data with machine learning and predictive analytics allows farmers to make quicker decisions about what needs modifications in the field before it’s too late, reducing irrigation where sensors can tell that conditions are moist enough, for example, or applying a soil amendment mid-season to correct for deficiencies. “Drone and camera-based technologies often catch problems in the field once visible on the plant, but at Teralytic, we try to catch these problems before they happen by diagnosing the soils,” said Steven Ridder, Founder and CEO of Teralytic.

For more information, contact Steven Ridder at steve@teralytic.com or call (646) 883-9181.

SOURCE: Teralytic

ReleaseID: 474025

NEW YORK, NY / ACCESSWIRE / August 29, 2017 / Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Forterra, Inc. (“Forterra” or the “Company”) (NASDAQ: FRTA) of the October 13, 2017 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

If you purchased Forterra common stock issued pursuant and/or traceable to Company’s October 21, 2016 initial public offering (the “IPO”)
and/or between October 18, 2016 and August 14, 2017 and would like to discuss your legal rights, click here: www.faruqilaw.com/FRTA. There is no cost or obligation to you.

You can also contact us by calling Richard Gonnello toll free at
877-247-4292 or at 212-983-9330 or by sending an e-mail to
rgonnello@faruqilaw.com.

The lawsuit has been filed in the U.S. District Court for the Eastern District of New York on behalf of all those who purchased Forterra common stock issued pursuant and/or traceable to the Company’s IPO and/or between October 18, 2016 and August 14, 2017. The case, Disayawathana
v. Forterra, Inc. et al No. 2:17-cv-04824 was filed on August 16, 2017, and has been assigned to Judge Arthur Donald Spatt.

The lawsuit focuses on whether the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that (1) the Company’s initiatives were not producing organic growth; (2) as such, the Company was not likely to experience organic growth; (3) the Company was facing increased pricing pressures, operational problems at is plants, and rising bad debt expenses; (4) the Company had material weaknesses in internal controls relating to inventory accounting; (5) as a result of the foregoing, Defendants’ statements were false and misleading.

Specifically, on May 15, 2017, the Company issued a press release revealing that it had created no organic growth for the first quarter of 2017. The Company also stated that it was continuing to work on its previously announced initiatives to improve income from operations, and that the Company expects these initiatives to require significant investment.

On this news, the Company’s stock price fell from $19.72 per share on May 12, 2017, to a closing price of $14.93 per share on May 15, 2017 – a $4.79 or a 24.29% drop.

Then, on August 10, 2017, the Company issued another press release, this time disclosing that it had produced no organic growth for the second quarter of 2017. The Company claimed that net sales were negatively Tropical Storm Cindy, excessive rainfall events around the country, unanticipated competitive pricing pressure in certain areas, and a decline in average sales prices of products sold.

Following this disclosure, Forterra’s share price declined from $8.27 on August 9, 2017, to a closing price of $3.51 on August 10, 2017 – a $4.76 or a 57.56% drop.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.

Faruqi & Faruqi, LLP also encourages anyone with information regarding Forterra’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

CONTACT:

FARUQI & FARUQI, LLP
685 Third Avenue, 26th Floor
New York, NY 10017
Attn: Richard Gonnello, Esq.
rgonnello@faruqilaw.com
Telephone: (877) 247-4292 or (212) 983-9330

SOURCE: Faruqi & Faruqi, LLP

ReleaseID: 474059

IRVINE, CA / ACCESSWIRE / August 29, 2017 / Khang & Khang LLP (the “Firm”) announces a securities class action lawsuit against Tahoe Resources Inc. (“Tahoe” or the “Company”) (NYSE: TAHO). Investors who purchased or otherwise acquired Tahoe shares from March 12, 2015 through July 5, 2017, inclusive (the “Class Period”), should contact the firm before the September 5, 2017 lead plaintiff motion deadline.

If you purchased Tahoe shares during the Class Period, please contact Joon M. Khang, Esq., of Khang & Khang LLP, 4000 Barranca Parkway, Suite 250, Irvine, CA 92604, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

There has been no class certification in this case yet, and until certification occurs, you are not represented by an attorney. You may also choose to take no action and remain a passive class member.

According to the Complaint, throughout the Class Period, Tahoe made false and/or misleading statements and/or failed to disclose: that consultation obligations in connection with the permitting of the Escobal mining license were unfulfilled; that the Escobal mining license is subject to suspension; and that as a result of the foregoing, the Company’s public statements were materially false and misleading at all relevant times. On July 5, 2017, Tahoe disclosed that the Supreme Court of Guatemala issued a provisional decision suspending the Escobal mining license of its subsidiary Minera San Rafael, in relation to an action brought by CALAS against Guatemala’s Ministry of Energy and Mines (“MEM”). CALAS alleges that MEM violated the Xinca Indigenous people’s right of consultation in advance of granting the Escobal mining license. Following this news, Tahoe’s stock price declined materially, which caused investors harm according to the Complaint.

If you wish to learn more about this lawsuit, or if you have questions about this notice or your rights, please contact Joon M. Khang, a prominent litigator for nearly two decades, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contact

Joon M. Khang, Esq.
Telephone: 949-419-3834
Facsimile: 949-225-4474
joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 474053

IRVINE, CA / ACCESSWIRE / August 29, 2017 / Khang & Khang LLP (the “Firm”) announces a securities class action lawsuit against Foundation Medicine, Inc. (“Foundation” or the “Company”) (NASDAQ: FMI). Investors who purchased or otherwise acquired Foundation shares from February 26, 2014 through November 3, 2015, inclusive (the “Class Period”), are encouraged to contact the Firm before the September 26, 2017 lead plaintiff motion deadline.

If you purchased Foundation shares during the Class Period, please contact Joon M. Khang, Esq., of Khang & Khang LLP, 4000 Barranca Parkway, Suite 250, Irvine, CA 92604, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

There has been no class certification in this case yet. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member as well.

According to the Complaint, throughout the Class Period, Foundation made false and/or misleading statements, and/or failed to disclose, material information to investors. On July 29, 2015, the Company announced that it was not making the strides obtaining coverage it claimed to have been making during the Class Period, and that Foundation would receive no Medicare payments in 2015 for its tumor profiling tests due to a delay in receiving a local coverage determination from its regional Medicare Administrative Contractor. As a result of the delay, the Company cut its 2015 financial guidance, which was based on an assumption that Medicare approval was going to be obtained in 2015. On this news, Foundation’s stock price fell significantly. On November 3, 2015, the Company revealed another revision to the already reduced number of clinical tests it expected to report for 2015. When this news reached the public, shares of Foundation declined in value materially, which harmed investors according to the lawsuit.

If you wish to learn more about this lawsuit, or if you have questions about this notice or your rights, please contact Joon M. Khang, Esq., a prominent litigator for almost two decades, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contact

Joon M. Khang, Esq.
Telephone: 949-419-3834
Facsimile: 949-225-4474
joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 474054

IRVINE, CA / ACCESSWIRE / August 29, 2017 / Khang & Khang LLP (the “Firm”) announces a securities class action lawsuit against Ocular Therapeutix, Inc. (“Ocular” or the “Company”) (NASDAQ: OCUL). Investors who purchased or otherwise acquired Ocular shares from May 5, 2017 through July 6, 2017, inclusive (the “Class Period”), are encouraged to contact the Firm before the September 5, 2017 lead plaintiff motion deadline.

If you purchased Ocular shares during the Class Period, please contact Joon M. Khang, Esq., of Khang & Khang LLP, 4000 Barranca Parkway, Suite 250, Irvine, CA 92604, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

There has been no class certification in this case yet, and until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member as well.

According to the Complaint, during the Class Period, Ocular made false and/or misleading statements and/or failed to disclose: that the Company’s management misled investors about DEXTENZA manufacturing issues, including that more than half of lots manufactured by the Company contain bad product; that such manufacturing issues could endanger the approval of DEXTENZA by the FDA; and that as a result, the Company’s public statements were materially false and misleading at all relevant times. On this news, Ocular’s stock price lowered materially, which caused investors harm according to the Complaint.

If you want to learn more about this lawsuit, or if you have questions about this notice or your rights, please contact Joon M. Khang, Esq., a prominent litigator for nearly two decades, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in certain jurisdictions.

Contact

Joon M. Khang, Esq.
Telephone: 949-419-3834
Facsimile: 949-225-4474
joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 474051

IRVINE, CA / ACCESSWIRE / August 29, 2017 / Khang & Khang LLP (the “Firm”) announces a securities class action lawsuit against Quadrant 4 System Corporation (“Quadrant 4” or the “Company”) (OTC PINK: QFOR). Investors who purchased or otherwise acquired Quadrant 4 shares from August 14, 2012 through June 30, 2017, inclusive (the “Class Period”), are encouraged to contact the Firm in advance of the September 5, 2017 lead plaintiff motion deadline.

If you purchased Quadrant 4 shares during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang LLP, 4000 Barranca Parkway, Suite 250, Irvine, CA 92604, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

There has been no class certification in this case yet. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member as well.

According to the Complaint, throughout the Class Period, Quadrant 4 made false and/or misleading statements and/or failed to disclose: that former Chief Executive Officer Nandu Thondavadi and former Chief Financial Officer Dhru Desai engaged in an accounting fraud scheme that misled investors; that Thondavadi and Desai took more than $4 million from the Company; that Thondavadi and Desai caused the Company to understate its liabilities, inflate its revenues and assets and evaded scrutiny by lying to Quadrant 4’s auditors and providing them with forged and doctored documents; and that as a result of the above, the Company’s public statements were materially false and misleading at all relevant times. When this news went public, shares of Quadrant 4 declined in value materially, which caused investors harm according to the Complaint.

If you wish to learn more about this lawsuit, or if you have any questions about this notice or your rights, please contact Joon M. Khang, Esq., a prominent litigator for nearly two decades, by telephone: (949) 419-3834, or via e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in certain jurisdictions.

Contact

Joon M. Khang, Esq.
Telephone: 949-419-3834
Facsimile: 949-225-4474
joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 474052

LOS ANGELES, CA / ACCESSWIRE / August 29, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Forterra, Inc. (“Forterra” or the “Company”) (NASDAQ: FRTA) concerning possible violations of federal securities laws in connection with its initial public offering (the “IPO”) on October 21, 2016. Investors who purchased or otherwise acquired Forterra shares in connection with the IPO should contact the firm prior to the October
13, 2017 lead plaintiff motion deadline.

To participate in this class action lawsuit, click here.

You can also call Brian Lundin, Esq., of Lundin Law PC, at 888-713-1033, or e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action yet. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.

According to the Complaint, the Registration Statement which Forterra used to conduct its IPO contained false and/or misleading statements, and/or failed to disclose material facts, specifically: that organic sales in the Company’s Drainage and Water segments significantly dropped; that Forterra was experiencing increased pricing pressure due to competition and continued softness in its concrete and steel pipe business; that the Company had been losing business in its important pipe and precast business, due in large part to operational problems at its production plants; and that Forterra had undisclosed material weaknesses in its internal controls that prevented it from accurately reporting and forecasting its financial results. Since the IPO date, Forterra’s stock price has fallen about 75%, which caused investors harm according to the Complaint.

Lundin Law PC was founded by Brian Lundin, Esq., a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.

This press release may be considered Attorney Advertising in certain jurisdictions under the applicable law and ethics rules.

Contact:

Lundin Law PC
Brian Lundin, Esq.
Telephone: 888-713-1033
Facsimile: 888-713-1125
brian@lundinlawpc.com
http://lundinlawpc.com/

SOURCE: Lundin Law PC

ReleaseID: 474050

LOS ANGELES, CA / ACCESSWIRE / August 29, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Sequans Communications S.A. (“Sequans” or the “Company”) (NYSE: SQNS) regarding possible violations of federal securities laws between April 29, 2016 and July 31, 2017, inclusive (the “Class Period”). Investors who purchased or otherwise acquired Sequans shares during the Class Period should contact the firm prior to the October 10, 2017 lead plaintiff motion deadline.

To participate in this class action lawsuit, click here.

You can also call Brian Lundin, Esq., of Lundin Law PC, at 888-713-1033, or e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action yet. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.

According to the Complaint, throughout the Class Period, Sequans made false and/or misleading statements, and/or failed to disclose, that the Company was improperly recognizing revenue, and as a result, its public statements were materially false and misleading at all relevant times. On August 1, 2017, Sequans revealed that its revenue in the second quarter was negatively affected by a product return from an early 2016 sale related to the tablet business. Upon this news, Sequans shares declined in value materially, which caused investors harm according to the lawsuit.

Lundin Law PC was founded by Brian Lundin, Esq., a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.

This press release may be considered Attorney Advertising in certain jurisdictions under the applicable law and ethics rules.

Contact:

Lundin Law PC
Brian Lundin, Esq.
Telephone: 888-713-1033
Facsimile: 888-713-1125
brian@lundinlawpc.com
http://lundinlawpc.com/

SOURCE: Lundin Law PC

ReleaseID: 474049